Possible fetal outcome of insulin aspart

Journal of Endocrinological Investigation

Volumn 31, Issue 9, 2008, Pages 841-

  Kanat, M ^a   Tahtaci, M ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; BEDTIME DOSAGE; CASE REPORT; CONGENITAL MALFORMATION; CORONARY ARTERY ANOMALY; DOSE RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS MALFORMATION; GENITAL SYSTEM DISEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; KIDNEY MALFORMATION; LETTER; MATERNAL AGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PROGNOSIS; VERTEBRA MALFORMATION;

EID: 57349128974     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349265     Document Type: Letter

References (3)

1. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 1979, 28: 292-3.
2. Hod M, Damm P, Kaaja R, et al; Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008, 198: 186.e1-7.
3. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. N Engl J Med 1997, 337: 1009-10.